These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antisense DNA and RNA strategies: new approaches to therapy. Gibson I J R Coll Physicians Lond; 1994; 28(6):507-11. PubMed ID: 7884705 [TBL] [Abstract][Full Text] [Related]
5. An indexed bibliography of antisense literature, 1991. Antisense Res Dev; 1992; 2(1):63-107. PubMed ID: 1422087 [No Abstract] [Full Text] [Related]
6. Oncogenes and growth factors in thyroid carcinogenesis. Frauman AG; Moses AC Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of oncogene expression using vector-generated RNA antisense. Whitesell L; Liu X; Bagatell R Methods; 1999 Jul; 18(3):296-303. PubMed ID: 10454988 [TBL] [Abstract][Full Text] [Related]
8. Specificity of interaction between receptor and G protein: use of antisense techniques to relate G-protein subunits to function. Kalkbrenner F; Dippel E; Wittig B; Schultz G Biochim Biophys Acta; 1996 Nov; 1314(1-2):125-39. PubMed ID: 8972726 [No Abstract] [Full Text] [Related]
9. [Anti-sense peptide]. Ding JF; Tang J Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):355-6. PubMed ID: 1302368 [No Abstract] [Full Text] [Related]
11. Angiogenic activity of the K-fgf/hst oncogene in neural transplants. Brüstle O; Aguzzi A; Talarico D; Basilico C; Kleihues P; Wiestler OD Oncogene; 1992 Jun; 7(6):1177-83. PubMed ID: 1375717 [TBL] [Abstract][Full Text] [Related]
12. [The application of antisense technology in ophthalmology]. Guo Y; Ge J Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046 [TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit. Nesterova M; Cho-Chung YS Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926 [TBL] [Abstract][Full Text] [Related]
14. Antisense approaches to cancer gene therapy. Mercola D; Cohen JS Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254 [TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides: an experimental strategy to advance a causal analysis of development. Slavkin HC Int J Dev Biol; 1995 Feb; 39(1):123-6. PubMed ID: 7626397 [TBL] [Abstract][Full Text] [Related]
18. Making sense from antisense: a review of experimental data and developing ideas on sense--antisense peptide recognition. Tropsha A; Kizer JS; Chaiken IM J Mol Recognit; 1992 Jun; 5(2):43-54. PubMed ID: 1472380 [TBL] [Abstract][Full Text] [Related]
19. [The biology of gliomas: growth factors and oncogene expression. A current review]. Westphal M; Herrmann HD Fortschr Neurol Psychiatr; 1988 Feb; 56(2):59-66. PubMed ID: 3283009 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice. Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]